NuVasive to Release $62.5M from Escrow Following Appeals Court Win
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today the release of $62.5 million from a restricted escrow account in relation to NuVasive's trademark dispute regarding the NeuroVision(R) trade name.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.